Bill
H 4730
Overview: H 4730, An Act establishing a Naloxone Purchase Trust fund, has been reported favorably by committee and referred to the committee on Health Care Financing. The bill was
Overview: H 4730, An Act establishing a Naloxone Purchase Trust fund, has been reported favorably by committee and referred to the committee on Health Care Financing. The bill was introduced on November 13, 2025.
Purpose and Intent: The main purpose of this bill is to establish a Naloxone Purchase Trust fund to help increase the availability and accessibility of the opioid overdose reversal drug naloxone. The legislation aims to address the ongoing opioid crisis and save lives by making this critical medication more widely distributed.
Key Provisions:
- Creates the Naloxone Purchase Trust fund, a dedicated state fund to purchase and distribute naloxone
- Authorizes the fund to receive appropriations, grants, and other revenue sources
- Requires the Department of Public Health to administer the fund and oversee naloxone distribution
Affected Parties and Impacts: The primary affected parties are individuals at risk of opioid overdose, as well as first responders, healthcare providers, and community organizations that will have increased access to naloxone. The legislation has the potential to reduce opioid-related fatalities.
Procedural and Timeline Considerations: The bill has been reported favorably by committee and referred to the committee on Health Care Financing for further consideration. It will need to pass additional legislative hurdles before potentially being enacted into law.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
